METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Clinical trials for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called tuvusertib combined with other cancer treatments in people with advanced solid tumors that have stopped responding to standard therapy. The main goals are to find safe doses and understand side effects. About 120 adults with various …
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
New drug combo tested for hard-to-treat cancers
Disease control OngoingThis early-phase study tests a new drug called tuvusertib, given alone or with another drug (niraparib), in people with advanced solid tumors that no longer respond to standard therapies. The main goals are to check safety, find the right dose, and see if the drug can shrink tumo…
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC